Frank M. Armstrong

Frank M. Armstrong has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Juniper Pharmaceuticals Inc and Curagen Corp. In total, 13 filings cover trades dated from 29 March 2006 to 30 June 2017.

In open-market terms, that means 3 purchases worth €21k on one side and 2 sales worth €32k on the other. The net balance comes to €11k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 8 share grants.

In size, the median ticket on the buying side is €8,847.

Most recently, on 5 July 2017, the filings show a share grant in Juniper Pharmaceuticals Inc. The latest purchase dates back some time: it was published 3,729 days ago, on 24 August 2016. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.